Skip to content

Clinical Evaluation of the SonR atrial lead in the Paradym RF device

Clinical Evaluation of the SonR atrial lead in the Paradym RF device - Klinische evaluatie van de SonR atriale electrode in de Paradym RF ICD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34489
Enrollment
20
Registered
2010-11-23
Start date
2010-12-14
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure ventricular dysssynchrony

Interventions

None listed

Sponsors

Sorin Group Nederland N.V.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Indication for a biventricular defibrillator and chronic heart failure.

Exclusion criteria

Exclusion criteria: Contra-indication for standard pacing. Contra-indication for ICD therapy. Acute myocarditis.

Design outcomes

Primary

MeasureTime frame
Atrial lead complication rate superior to 90% after 3 months. Comparison of automatic and manual right ventricular stimulation threshold after 1 month.

Secondary

MeasureTime frame
Report Serious Adverse Events and Adverse Events. Report electrical functionality of the ICD. Report electrical functionality of the SonR atrial lead. Report hemodynamic performance measurements from the SonR atrial lead.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)